Abstract
No public abstract is available from the verified source records.
Michael Shlossman, Daniel P Cook
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local citing links have been materialized yet.
Origins of cystic fibrosis lung disease
10.1056/nejmra1300109 · 2015
Update on innate and adaptive immunity in cystic fibrosis
10.1016/j.ccm.2022.06.004 · 2022
Cystic fibrosis and the cells of the airway epithelium: what are ionocytes and what do they do?
10.1146/annurev-pathol-042420-094031 · 2022
CFTR negatively reprograms Th2 cell responses, and CFTR potentiation restrains allergic airway inflammation
10.1172/jci.insight.191098 · 2025
CFTR is a negative regulator of γδ T cell IFN-γ production and antitumor immunity
10.1038/s41423-020-0499-3 · 2021
T cell metabolism drives immunity
10.1084/jem.20151159 · 2015
Metabolic alterations in cystic fibrosis lymphocyte memory accompanies restoration of CFTR function
10.1093/ajrcmb/aanag081 · 2026
Inflammation in preschool cystic fibrosis is of mixed phenotype, extends beyond the lung and is differentially modified by CFTR modulators
10.1136/thorax-2024-221634 · 2025
Perinatal dysfunction of innate immunity in cystic fibrosis
10.1126/scitranslmed.adk9145 · 2025
Heightened mitochondrial respiration in CF cells is normalised by triple CFTR modulator therapy through mechanisms involving calcium
10.1016/j.heliyon.2024.e39244 · 2024
CFTR modulators for the treatment of chronic obstructive pulmonary disease: the jury is still out!
10.1164/rccm.202409-1878ed · 2025
No additional external references are available.